Replies to post #274125 on Amarin Corp Plc (AMRN)

[Bill B]

The evaporate study was scheduled to end May 15 and preliminary results to follow shortly with the final report due in August. As for NASH that was supposed to end in May also. I read a comment on another board a couple of weeks ago that another cohort had been added to the NASH study that included vascepa. Good news if true I think.